# Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction

> **NCT07139912** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd** · enrollment: 96 (estimated)

## Conditions studied

- Aortic Arch Disease

## Interventions

- **DEVICE:** Thoracic Aortic Multi-Branch Stent Graft System

## Key facts

- **NCT ID:** NCT07139912
- **Lead sponsor:** Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2028-03
- **Final completion:** 2032-03
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07139912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07139912, "Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07139912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*